跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 150 条关于
“GABAA”
全部
150
临床试验
95
药物
23
机构
1
资讯
31
去年
Luye Pharma Initiates Phase 1 Trial for Novel Triple-Target Antidepressant LY03021
去年
Algiax's AP-325 Shows Promise in Phase 2a Trial for Neuropathic Pain
去年
Seaport Therapeutics' SPT-300 Shows Promise in Phase I Trial for Neurological Conditions
10个月前
RespireRx Secures $1.5M NIH Grant to Advance Novel Epilepsy Treatment KRM-II-81 Toward Clinical Trials
3年前
Lipocine Pivots to CNS Disorders with Oral Neuroactive Steroid Pipeline
10个月前
Axsome Therapeutics Acquires Novel GABA-A Receptor Modulator AZD7325 for Epilepsy Treatment
去年
FDA Panel Approves Sage's Novel Antidepressant for Postnatal Depression, Rejects Alkermes' Treatment
5个月前
Addex GABAB PAM Candidate Shows Promising Anti-Cough Activity in Non-Human Primate Studies
去年
Major Depressive Disorder Pipeline Advances with 75+ Companies Developing Novel Therapies
去年
Umecrine Cognition's Phase 1b/2a Trial of Golexanolone for PBC Faces Temporary Delay Due to Manufacturing Issues
第 1 页,共 4 页
上一页
下一页